A cervical cancer vaccine from GlaxoSmithKline (GSK) prevents lesions, the FDA found as it...

|About: GlaxoSmithKline (GSK)|By:, SA News Editor

A cervical cancer vaccine from GlaxoSmithKline (GSK) prevents lesions, the FDA found as it considers an end-of-month approval of the first competitor to Merck's (MRK) Gardasil. More miscarriages were reported with the GSK drug, Cervarix, though the FDA says the data "do not establish a causal relationship."